Neuropharmacology as a branch of pharmacology evolved with the introduction of drugs for neurologic disorders. It is the study of the effects of drugs on the nervous system, with the goal of developing compounds that offer therapeutic benefit in humans with psychiatric and neurological disease. Advances in molecular biology and various forms such as genomics and proteomics have led to the development of molecular neuropharmacology. Alzheimer disease as just one example, are awaiting effective medications, further emphasizing the importance of neuropharmacology. It includes the factors affecting responses to drugs; properties of drugs; the kinetics of drug-receptor interactions; dose-response relationship; the principles of synaptic transmission; criteria for synaptic transmitters; somatic motor system; drugs affecting neuromuscular transmission; and drugs which act post-synaptically. 

  • Track 1-1 Behavioural and Molecular Approach
  • Track 2-2 Application of Neuropsychopharmacology
  • Track 3-3 Emerging approach in the field of Cognitive Neuropharmacology
  • Track 4-4 Global trend in Drug Discovery related to Neuropsychiatric Disorders

Related Conference of Pharmaceutical Sciences